Jack Ma's health-care buyout is a bitter pill for shareholders to swallow

Jack Ma's buyout of US-listed iKang Healthcare Group is a bitter pill for shareholders to swallow. Here's why.

from Mergers and Acquisitions http://ift.tt/1tkCzVw